This suggests that the PIK3CA mutation copy number might have potential as a clinical marker for evaluating tumor burden in SNs, as it showed a trend consistent with CK19 mRNA levels.
← all excerpts
Analysis of <i>PIK3CA</i> mutations in the lysate of sentinel lymph nodes in patients with early breast cancer.
1
—
—